➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Merck
Medtronic

Last Updated: October 1, 2020

DrugPatentWatch Database Preview

Litigation Details for Uniloc 2017 LLC v. Microsoft Corporation (C.D. Cal. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Uniloc 2017 LLC v. Microsoft Corporation (C.D. Cal. 2018)

Docket   Start Trial Date Filed 2018-11-17
Court District Court, C.D. California Date Terminated 2019-08-09
Cause 35:271 Patent Infringement Assigned To Josephine L. Staton
Jury Demand Plaintiff Referred To John D. Early
Parties MICROSOFT CORPORATION; UNILOC 2017 LLC
Patents 6,110,953; 6,706,724; 6,858,664; 7,955,196; 7,956,167; 8,858,973; 9,676,783; 9,745,577; 9,956,467
Attorneys Aamir A Kazi; Allen W Wang; Benjamin K Thompson; Chase Scolnick; David E Killough; David L Alberti; Hong Syd Lin; Indranil Mukerji; James Huguenin-Love; James P Gagen; Jeremiah A Armstrong; Juanita Rose Brooks; Kate E Hart; Katherine H Reardon; M Elizabeth Day; Marc C Belloli; Robert Francois Kramer; Roger A Denning; Russell S Tonkovich; Sal Lim; Shamita D Etienne-Cummings; Steven R Katz
Firms Feinberg Day Kramer Alberti Lim Tonkovich and Belloli LLP; Fish & Richardson; Fish & Richardson PC; Fish and Richardson PC; James Huguenin-Love; Keller Anderle LLP; Microsoft Corporation; White and Case; White and Case LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Uniloc 2017 LLC v. Microsoft Corporation
The small molecule drug covered by the patents cited in this case is   Start Trial .
Biologic Drugs cited in Uniloc 2017 LLC v. Microsoft Corporation

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for Uniloc 2017 LLC v. Microsoft Corporation (C.D. Cal. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-04-27 111 Status Report the “’487 patent”); and 7,092,953 (the 21 “’953 patent”). 22 The patents-in-suit …7,020,252 (the “’252 patent”), 7,167,487 10 (the “’487 patent”), 7,092,953 (the “’953 patent”), 8,724,622… ’273 patent and the ’953 patent will also overlap because Uniloc asserts the ’273 5 and ’953 patents…8,606,856 (the “’856 patent”); 7,020,252 (the “’252 patent”); 8,613,110 20 (the “’110 patent”); 7,024,696…seven of the patents-in-suit have 27 been denied (’487, ’252, ’856, ’636, ’953, ’622 and ’273 External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
McKesson
McKinsey
Dow
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.